Pre-training inter-rater reliability of clinical instruments in an international psychosis research project

Affiliations

• ¹ Department of Psychiatry, Amsterdam UMC, Amsterdam, The Netherlands; Arkin Institute for Mental Health, Amsterdam, The Netherlands. Electronic address: s.berendsen@amsterdamumc.nl.
• ² Department of Psychiatry, Amsterdam UMC, Amsterdam, The Netherlands.
• ³ Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, England, UK.
• ⁴ Department of Health Service and Population Research, Institute of Psychiatry, King's College London, London, UK.
• ⁵ Department of Psychology, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
• ⁶ Amsterdam Public Mental Health Research Institute, Department of Clinical Psychology, Faculty of Behavioural and Movement Sciences, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
• ⁷ PsyLife Group, Division of Psychiatry, UCL, London, England, UK.
• ⁸ PsyLife Group, Division of Psychiatry, UCL, London, England, UK; Department of Psychiatry, University of Cambridge, Cambridge, England, UK.
• ⁹ Department of Psychiatry, University of Cambridge, Cambridge, England, UK.
• ¹⁰ Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad Complutense, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Spanish Mental Health Research Network (CIBERSAM), Madrid, Spain.
• ¹¹ Department of Psychiatry, Instituto de Investigación Sanitaria (IDIS), Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain.
• ¹² Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Spanish Mental Health Research Network (CIBERSAM), Spain.
• ¹³ Department of Psychiatry, Hospital Clínico Universitario de Valencia, School of Medicine, Universidad de Valencia, Valencia, Spain.
• ¹⁴ Department of Psychiatry, Hospital "Virgen de la Luz", Cuenca, Spanish Mental Health Research Network (CIBERSAM), Spain; INSERM, U955, Créteil, France.
• ¹⁵ INSERM, U955, "Translational NeuroPsychiatry Lab", Créteil 94000, France.
• ¹⁶ Etablissement Public de Santé Maison Blanche, Paris, France.
• ¹⁷ Centre Hospitalier Universitaire de Clermont-Ferrand, Clermont-Ferrand, France.
• ¹⁸ Department of Medical and Surgical Sciences, Psychiatry Unit, Alma Mater Studiorum Università di Bologna, Bologna, Italy.
• ¹⁹ Department of Biomedicine, Neuroscience and Advanced Diagnostics, University of Palermo, Palermo, Italy.
• ²⁰ Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement, University of Verona, Verona, Italy.
• ²¹ Department of Preventive Medicine, Faculdade de Medicina, Universidade of São Paulo, São Paulo, Brazil.
• ²² Ribeirão Preto Medical School, University of São Paulo, Brazil.
• ²³ Orygen, Parkville, Victoria, Australia; Centre for Youth Mental Health, The University of Melbourne, Parkville, Victoria, Australia.
• ²⁴ Medizinische Fakultät, Universität Basel, Basel, Switzerland.
• ²⁵ LiNC-Lab Interdisciplinar Neurociências Clínicas, Depto Psiquiatria, Escola Paulista de Medicina, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil.
• ²⁶ Departament de Psicologia Clínica i de la Salut, Universitat Autònoma de Barcelona, Barcelona, Spain; Fundació Sanitària Sant Pere Claver, Spanish Mental Health Research Network (CIBERSAM), Spain.
• ²⁷ University of Paris, GHU-Paris, Sainte-Anne, C'JAAD, Inserm U1266, Institut de Psychiatrie (CNRS 3557), Paris, France.
• ²⁸ Mental Health Center Copenhagen and Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research, CINS, Mental Health Center Glostrup, Mental Health Services in the Capital Region of Copenhagen, University of Copenhagen, Copenhagen, Denmark.
• ²⁹ Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.
• ³⁰ Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.
• ³¹ Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, The Netherlands.
• ³² Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, England, UK; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, The Netherlands; Department of Psychiatry, Brain Centre Rudolf Magnus, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
• ³³ Department of Psychiatry, Amsterdam UMC, Amsterdam, The Netherlands; Seaver Center for Research and Treatment, Icahn School of Medicine at Mount Sinai, NY, USA; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, NY, USA.
• ³⁴ Department of Psychiatry, Amsterdam UMC, Amsterdam, The Netherlands; Arkin Institute for Mental Health, Amsterdam, The Netherlands.
• ³⁵ Parnassia Psychiatric Institute, Department of Psychosis Research, Zoutkeetsingel 40, 2512 HN The Hague, The Netherlands.
• ³⁶ Orygen, Parkville, Victoria, Australia.
• ³⁷ University of Basel, Basel, Switzerland.
• ³⁸ Department of Psychiatry, Escola Paulista de Medicina, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil.
• ³⁹ CONACYT-Dirección de Investigaciones Epidemiológicas y Psicosociales, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Mexico.
• ⁴⁰ Fundació Sanitària Sant Pere Claver, Spanish Mental Health Research Network (CIBERSAM), Spain.
• ⁴¹ Department of Psychology, University of Illinois at Urbana-Champaign, IL, USA.
• ⁴² Centre for Neuropsychiatric Schizophrenia Research (CNSR) & Centre for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS), Mental Health Centre Glostrup, University of Copenhagen, Glostrup, Denmark.
• ⁴³ Psyberlin, Berlin, Germany.